What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography

Learn more about:
Related Clinical Trial
Radiofrequency Ablation of Adenomyosis Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis The Effect of Adenomoyosis on Pregnancy Outcomes Observational Study of Patients Suffering From Endometriosis and Adenomyosis Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis Quality of Life After Hysterectomy (AdenoQOL) Low Molecular Weight Heparin on the Adenomyosis Patients’IVF-ET Outcome Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI Clinical and Molecular Study of Endometriosis and Adenomyosis Surgical Success After Laparoscopic vs Abdominal Hysterectomy Electronic Catheter Stethoscope Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Uterine Artery Embolization for Symptomatic Fibroids Oxytocin in MRI-HIFU To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy Effect of Addition of Steroids on Duration of Analgesia Paracervical Block in Laparoscopic Hysterectomy Use of Dexamethasone in Uterine Artery Embolization Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) Dienogest for Treatment of Adenomyotic Uteri Health-Related QoL Among Women Receiving Hysterectomy in NTUH Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis Adenomyosis and Ulipristal Acetate Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis LNG-IUS for Treatment of Dysmenorrhea Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis Adenomyosis: Genomic Mechanisms and Biological Response What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis A Prospective Study of Diagnostic Accuracy of Ultrasound Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis A Multi-omics Study of Adenomyosis Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis Levonorgestrel Intrauterine System and Adenomyosis Validation of the Adenomyosis Calculator Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer. New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Norwegian Adenomyosis Study III: Peristalsis Histopathological Diagnosis of Adenomyosis Norwegian Adenomyosis Study I Vaginal Bromocriptine for Treatment of Adenomyosis Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Brief Title

What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography

Official Title

What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography

Brief Summary

      To improve the clinical care of women with pelvic pain and abnormal uterine bleeding due to
      benign uterine conditions including leiomyomas (uterine fibroids) and adenomyosis by
      evaluating the accuracy of radiology diagnostic exams (MRI(magnetic resonance imaging),
      ultrasound and ultrasound with elastography).
    

Detailed Description

      Currently benign conditions of the uterus are frequently underdiagnosed or misdiagnosed. This
      project will help determine which diagnostic radiology exams are most helpful to the
      clinician in providing accurate diagnosis. In addition, this study will evaluate which exam
      (MRI vs. Ultrasound) patients prefer over another exam.
    

Study Phase

Early Phase 1

Study Type

Interventional


Primary Outcome

Diagnostic accuracy of MRI and ultrasound elastography for distinguishing adenomyosis and fibroids

Secondary Outcome

 Patient preference between ultrasound and MRI

Condition

Uterine Bleeding

Intervention

Evaluation of MRI, US for pelvic and uterine conditions

Study Arms / Comparison Groups

 Evaluation of MRI, US for pelvic conditions
Description:  MRI and ultrasound imaging will be used clinically to evaluate pelvic pain and abnormal uterine bleeding. The goal is to determine which exams are most helpful to the clinician in providing an accurate diagnosis as well as evaluating patient preference.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Procedure

Estimated Enrollment

49

Start Date

November 2013

Completion Date

March 2018

Primary Completion Date

March 2018

Eligibility Criteria

        Inclusion Criteria:

          1. 18 years of age or older

          2. Pelvic pain and/or abnormal uterine bleeding. (this is specific for Arm. 1 of this
             study)

          3. If you have had or are scheduled to have both a pelvic MRI (magnetic resonance
             imaging) and a pelvic ultrasound with 6 months of the time of enrollment. (this is
             specific to Arm 2 of this study).

             -

        Exclusion Criteria:

          1. If you are post-menopausal(have not had a period in at least one year's time).

          2. If you have been diagnosed with gynecological malignancy such as uterine, endometrial,
             cervical or ovarian cancer.

          3. If you are unable or unwilling to sign the informed consents

          4. If you are unable to undergo the research study exams -
      

Gender

Female

Ages

18 Years - N/A

Accepts Healthy Volunteers

No

Contacts

Katherine Maturen, MD, MS, , 

Location Countries

United States

Location Countries

United States

Administrative Informations


NCT ID

NCT01992718

Organization ID

HUM00076620


Responsible Party

Principal Investigator

Study Sponsor

University of Michigan

Collaborators

 Association of University Radiologists

Study Sponsor

Katherine Maturen, MD, MS, Principal Investigator, University of Michigan


Verification Date

May 2018